American Gene Technologies®
In The News
BioBuzz: American Gene Technologies Spins Off Addimmune as a Separate Company With a Focus on Curing HIV
Original Post in BioBuzz. By: Alex Keown Powered by promising Phase I results from its HIV gene and cell therapy, American Gene Technologies (AGT) is spinning off a new company dedicated solely to develop a cure for a disease Chief Executive Officer Jeff Galvin calls ‘insidious.”…
Read More
Washington Business Journal: Rockville’s AGT Launches Spinout Addimmune
Original Post in WBJ. By: Sara Gilgore Rockville’s American Gene Technologies is spinning off a new company that will look to raise millions of dollars in funding and potentially go public – with an ambitious goal of curing HIV. The private, 16-year-old biotech, which…
Read More
My MC Media: Rockville Company Launches Spinoff Focused on Curing HIV
Original Post in MyMCMedia. By: Suzanne Pollak American Gene Technologies (AGT) in Rockville is ramping up efforts to develop a possible cure for HIV, announcing Friday it has launched a spinoff company that will focus exclusively on HIV, human immunodeficiency virus. AGT CEO Jeff…
Read More
The Patch: Promising Data on Gene Cell Therapy for HIV Cure from Rockville Firm
Original Post in The Patch. By: Michael O’Connell American Gene Technologies, a Rockville-based biotech firm, announced on Friday that it was standing up a new company to oversee its HIV treatment project, which recently completed Phase 1 of its clinical trial. “When we did…
Read More
MoCo 360: Rockville Biotech Company Sets Its Sights on Curing HIV
Original Post in MoCo 360. A Rockville gene therapy company is determined to find a cure for HIV – and recent studies suggest it might be on the right track. American Gene Technologies, a 15-year-old company founded and run by CEO Jeff Galvin, conducted…
Read More
Morningside Maryland: Rockville Firm Reports Promising Data on Gene Cell Therapy for HIV Cure
Original Post in Morningside Maryland. A Rockville-based biotech firm, American Gene Technologies (AGT), has reported promising data on its gene cell therapy for HIV cure. The treatment, which involves genetically modifying a patient’s immune cells to target and eliminate HIV-infected cells, has shown significant promise…
Read More
From Lab to Launch Podcast: Pioneering Treatment of HIV with Dr. Marcus Conant
Have a listen. From Lab to Launch by Qualio Marcus A. Conant, MD is the Chief Medical Officer at American Gene Technologies. Dr. Conant is a physician who treated thousands of HIV patients in the early 80s while running the inpatient dermatology service at the…
Read More
PharmaVoice: This biotech’s ‘Microsoft’ approach could change how we see gene therapy
Original post on PharmaVoice.com The company’s using a unique component-based platform to develop functional cures for diseases, including HIV. Welcome to Biotech Spotlight, a series featuring companies that are creating breakthrough technologies and products. Today, we’re looking at American Gene Technologies and its…
Read More
POZ Magazine: HIV Advocates Inspire in “The Cure Chronicles”
Original post on Poz.com By Trent Straube Sexual molestation as a child, an abusive father, the foster care system, violent street gangs, an HIV diagnosis as a teenager. “Anything you can think of that’s bad, I’ve been through it,” says Latina HIV advocate Maria Mejia in an episode of The…
Read More
Biotech Project Podcast: ‘It’s easy to be excited’ -Jeff Galvin on American Gene’s Unique Gene Therapy Technology
The Biotech Project podcast welcomes CEO and Founder of American Gene Technologies®, Jeff Galvin, onto the show to discuss the past, present, and future of the company’s mission to use the power of gene therapy to relieve human suffering from serious diseases. Hosts Scott J…
Read MoreSubscribe to News Releases and News Updates
Subscribe to our news release and published article updates to be notified when we release new content!
Follow AGT on Social Media
AGT on Facebook
